Skip to main content
The Bright Side
arrow_backHome
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Business & Technology
TechCrunchEN
September 23, 2026

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Read More

Curated from TechCrunch. Classified as Business & Technology by AI, which sometimes makes mistakes.

Why are you reporting this article?

Why are you reporting this article?
0/500

More like this

More ›